1. Home
  2. BHVN
  3. BHVN News

Latest Biohaven Ltd. (BHVN) News on October 8, 2025

BHVN

Investing.com

25 days ago

Biotech stocks: Who wins and who loses if RFK, Jr. goes

Why Biohaven Stock Zoomed More Than 6% Higher Today
BHVN

Motley Fool

2 months ago

Why Biohaven Stock Zoomed More Than 6% Higher Today

Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
BHVN

Investor's Business Daily

2 months ago

Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?

BHVN

MT Newswires

2 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

BHVN

MT Newswires

2 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

BHVN

MT Newswires

2 months ago

Biohaven Says US FDA Deems Advisory Committee Meeting No Longer Needed on Troriluzole

Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting
BHVN

Benzinga

2 months ago

Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting

FDA cancels adcomm on Biohaven drug; Catalent lays off staff
BHVN

BioPharma Dive

2 months ago

FDA cancels adcomm on Biohaven drug; Catalent lays off staff

RBC says PTC Therapeutics CRL may signal difficulty for Biohaven
BHVN

TipRanks

2 months ago

RBC says PTC Therapeutics CRL may signal difficulty for Biohaven

Biohaven Insiders Added US$6.28m Of Stock To Their Holdings
BHVN

Simply Wall St.

4 months ago

Biohaven Insiders Added US$6.28m Of Stock To Their Holdings

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
BHVN

GlobeNewswire

4 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor
BHVN

PR Newswire

4 months ago

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy
BHVN

Insider Monkey

4 months ago

Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)
BHVN

PR Newswire

4 months ago

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors
BHVN

PR Newswire

4 months ago

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

Why Biohaven Stock Dove by Nearly 20% on Thursday
BHVN

Motley Fool

5 months ago

Why Biohaven Stock Dove by Nearly 20% on Thursday

Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug
BHVN

Investor's Business Daily

5 months ago

Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug

Why Is Biohaven Stock Falling On Thursday?
BHVN

Benzinga

5 months ago

Why Is Biohaven Stock Falling On Thursday?

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia
BHVN

PR Newswire

5 months ago

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments
BHVN

PR Newswire

5 months ago

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments

Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts
BHVN

Insider Monkey

5 months ago

Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts

Why BioHaven Stock Is Soaring Today
BHVN

Motley Fool

5 months ago

Why BioHaven Stock Is Soaring Today

Biohaven Announces Investment up to $600 Million by Oberland Capital
BHVN

PR Newswire

5 months ago

Biohaven Announces Investment up to $600 Million by Oberland Capital

Biohaven share price undervaluing pipeline potential, says RBC Capital
BHVN

TipRanks

5 months ago

Biohaven share price undervaluing pipeline potential, says RBC Capital

Why Biohaven Stock Plummeted by More Than 15% Today
BHVN

Motley Fool

5 months ago

Why Biohaven Stock Plummeted by More Than 15% Today

Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21
BHVN

Insider Monkey

5 months ago

Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21

Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
BHVN

Insider Monkey

6 months ago

Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting
BHVN

PR Newswire

6 months ago

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
BHVN

Motley Fool

6 months ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

American Century Companies boosts stake in Biohaven, ETF Daily News says
BHVN

TipRanks

6 months ago

American Century Companies boosts stake in Biohaven, ETF Daily News says

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
BHVN

GlobeNewswire

6 months ago

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025
BHVN

Insider Monkey

7 months ago

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025

Biohaven price target lowered to $63 from $69 at Morgan Stanley
BHVN

TipRanks

7 months ago

Biohaven price target lowered to $63 from $69 at Morgan Stanley

Estimating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
BHVN

Simply Wall St.

7 months ago

Estimating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
BHVN

Investor's Business Daily

7 months ago

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Company News for Mar 4, 2025
BHVN

Zacks

7 months ago

Company News for Mar 4, 2025

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
BHVN

PR Newswire

7 months ago

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results
BHVN

PR Newswire

7 months ago

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results

Why Biohaven Stock Triumphed on Tuesday
BHVN

Motley Fool

8 months ago

Why Biohaven Stock Triumphed on Tuesday

Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
BHVN

Investor's Business Daily

8 months ago

Biohaven Just Hurdled An FDA Setback — And Its Moving Lines

Why Biohaven (BHVN) Stock Is Rallying Today
BHVN

Insider Monkey

8 months ago

Why Biohaven (BHVN) Stock Is Rallying Today

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
BHVN

PR Newswire

8 months ago

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia

Pfizer to Pay $60 Million in Kickback, False Claims Settlement
BHVN

The Wall Street Journal

8 months ago

Pfizer to Pay $60 Million in Kickback, False Claims Settlement

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
BHVN

PR Newswire

9 months ago

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
BHVN

GlobeNewswire

9 months ago

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BHVN

PR Newswire

9 months ago

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares
BHVN

Simply Wall St.

9 months ago

Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares

Company News for Jan 2, 2025
BHVN

Zacks

9 months ago

Company News for Jan 2, 2025

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
BHVN

Benzinga

10 months ago

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval

Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
BHVN

Insider Monkey

10 months ago

Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates
BHVN

PR Newswire

10 months ago

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting
BHVN

PR Newswire

10 months ago

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study
BHVN

Benzinga

10 months ago

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
BHVN

PR Newswire

10 months ago

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments
BHVN

PR Newswire

a year ago

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments

Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy
BHVN

Investor's Business Daily

a year ago

Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy

Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy
BHVN

Investor's Business Daily

a year ago

Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy

BHVN

MT Newswires

a year ago

Biohaven Ltd Insider Bought Shares Worth $999,970, According to a Recent SEC Filing

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock
BHVN

Simply Wall St.

a year ago

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Pricing of $250 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
BHVN

PR Newswire

a year ago

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
BHVN

Zacks

a year ago

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More

BHVN

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 09/26/2024

BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
BHVN

Zacks

a year ago

BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal

Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
BHVN

PR Newswire

a year ago

Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)

Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia
BHVN

PR Newswire

a year ago

Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia

Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?
BHVN

Insider Monkey

a year ago

Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?

Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
BHVN

PR Newswire

a year ago

Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
BHVN

GlobeNewswire

a year ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series
BHVN

PR Newswire

a year ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029
BHVN

GlobeNewswire

a year ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights
BHVN

GlobeNewswire

a year ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results
BHVN

Insider Monkey

a year ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
BHVN

GlobeNewswire

a year ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages
BHVN

PR Newswire

a year ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032
BHVN

GlobeNewswire

a year ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day
BHVN

PR Newswire

a year ago

Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
BHVN

PR Newswire

a year ago

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors

BHVN

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 05/16/2024

Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)
BHVN

GuruFocus.com

a year ago

Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)

Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
BHVN

Zacks

a year ago

Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
BHVN

Zacks

a year ago

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround

Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
BHVN

PR Newswire

a year ago

Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments

Independent Director of Biohaven John Childs Buys 3.2% More Shares
BHVN

Simply Wall St.

a year ago

Independent Director of Biohaven John Childs Buys 3.2% More Shares

BHVN

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 04/26/2024

Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
BHVN

GuruFocus.com

a year ago

Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
BHVN

GuruFocus.com

a year ago

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
BHVN

PR Newswire

a year ago

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates

LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?
BHVN

TipRanks

2 years ago

LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?

Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock
BHVN

Simply Wall St.

2 years ago

Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock

Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
BHVN

PR Newswire

2 years ago

Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments

A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
BHVN

Simply Wall St.

2 years ago

A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)

Will PBF Energy (PBF) Beat Estimates Again in Its Next Earnings Report?
BHVN

Zacks

2 years ago

Will PBF Energy (PBF) Beat Estimates Again in Its Next Earnings Report?

Post Holdings Inc (POST) Reports Strong Q1 Fiscal 2024 Results, Raises Full-Year Guidance
BHVN

GuruFocus.com

2 years ago

Post Holdings Inc (POST) Reports Strong Q1 Fiscal 2024 Results, Raises Full-Year Guidance

Everhome Suites Continues Sustained Growth Across the Southwest with Six Groundbreakings
BHVN

PR Newswire

2 years ago

Everhome Suites Continues Sustained Growth Across the Southwest with Six Groundbreakings

Share on Social Networks: